Phase 4 COPD Trial, Recruiting (NCT05703919)

Phase 4 COPD Trial, Recruiting NCT05703919 Sponsor: Central Denmark Region Condition: COPD

Printed from Voxsanity (voxsanity.com.au) — NCT05703919 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Copd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are over 40 years of age
People where an EMT or Paramedic suspects they are having a flare-up of COPD (a lung condition)
People where COPD has been confirmed as a suspected diagnosis

Who may not be able to join:

People whose breathing difficulties are caused by asthma, an allergic reaction, or a condition other than COPD
People who are known to be pregnant or where pregnancy is suspected
People who have already received breathing assistance before hospital, such as a breathing mask with assisted airflow, or a breathing tube
People who have a known allergy to inhaled bronchodilators (a medication called Salbutamol, used to open the airways)
People who are being transferred between hospitals
People who have already received more than 2 doses (5 mg of Salbutamol) of inhaled treatment from emergency medical services before the trial treatment has been started
People where a heart attack or acute coronary syndrome is suspected

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Martin F Gude, PhD, Central Denmark Region

Phone: 0045 25343621

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05703919

Sponsor: Central Denmark Region

Phase: Phase 4

Status: Recruiting

Condition: COPD

Trial contact: 0045 25343621

More information: https://clinicaltrials.gov/study/NCT05703919

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are over 40 years of age
People where an EMT or Paramedic suspects they are having a flare-up of COPD (a lung condition)
People where COPD has been confirmed as a suspected diagnosis

Who may not be able to join:

People whose breathing difficulties are caused by asthma, an allergic reaction, or a condition other than COPD
People who are known to be pregnant or where pregnancy is suspected
People who have already received breathing assistance before hospital, such as a breathing mask with assisted airflow, or a breathing tube
People who have a known allergy to inhaled bronchodilators (a medication called Salbutamol, used to open the airways)
People who are being transferred between hospitals
People who have already received more than 2 doses (5 mg of Salbutamol) of inhaled treatment from emergency medical services before the trial treatment has been started
People where a heart attack or acute coronary syndrome is suspected

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Central Denmark Region

Registry

ClinicalTrials.gov

Start date

2 June 2025

Est. completion

31 May 2027

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Mortality, 30-day

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov